Skip to main content

Advertisement

Log in

Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Objectives

MicroRNAs regulate gene expression at the post-transcriptional level and play important roles in cancer development, progression, and metastasis. The aim of this study was to investigate the expression of miR-92a in colorectal cancer and the normal adjacent mucosa and its potential relevance to clinicopathological characteristics and patient survival.

Methods

Surgical specimens of cancer tissue and adjacent normal mucosa were obtained from 82 patients with colorectal carcinomas. The relative expression levels of miR-92a mRNA in the cancer and the normal adjacent mucosa were measured by quantitative real-time reverse transcriptase polymerase chain reaction. We analyzed their correlation with tumor metastasis, clinicopathologic parameters, and clinical outcome.

Results

The relative expression levels of miR-92a were significantly higher in colorectal cancer tissues than in the normal adjacent mucosa (p < 0.001), and a high expression of miR-92a correlated with advanced clinical stage (p = 0.025), lymph node metastases (p = 0.015), and distant metastases (p = 0.046). Kaplan–Meier analysis indicated that patients with high miR-92a expression had a poor overall survival (p = 0.001). Moreover, multivariate analysis showed that increased expression of miR-92a was an independent predictor of overall survival.

Conclusion

This study revealed that miR-92a overexpression was correlated with specific colorectal cancer biopathologic features, such as TNM stage, lymph node and distant metastases, and poor survival of the patients, indicating that miR-92a may serve as a molecular prognostic marker for colorectal cancer and disease progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Huang Z, Huang D, Ni S et al (2010) (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127(1):118–126

    Article  PubMed  CAS  Google Scholar 

  2. Sun L, Hu H, Peng L et al (2011) P-cadherin promotes liver metastasis and is associated with poor prognosis in colon cancer. Am J Pathol 179(1):380–390

    Article  PubMed  CAS  Google Scholar 

  3. Li XM, Wang AM, Zhang J et al (2011) Down-regulation of miR-126 expression in colorectal cancer and its clinical significance. Med Oncol 28(4):1054–1057

    Article  PubMed  Google Scholar 

  4. Lagos-Quintana M, Rauhut R, Lendeckel W et al (2001) Identification of novel genes coding for small expressed RNAs. Science 294(5543):853–858

    Article  PubMed  CAS  Google Scholar 

  5. Lau NC, Lim LP, Weinstein EG et al (2001) An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294(5543):858–862

    Article  PubMed  CAS  Google Scholar 

  6. Lee RC, Ambros V (2001) An extensive class of small RNAs in Caenorhabditis elegans. Science 294(5543):862–864

    Article  PubMed  CAS  Google Scholar 

  7. Esquela-Kerscher A, Slack FJ (2006) Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6(4):259–269

    Article  PubMed  CAS  Google Scholar 

  8. Ambros V (2004) The functions of animal microRNAs. Nature 431(7006):350–355

    Article  PubMed  CAS  Google Scholar 

  9. Hayashita Y, Osada H, Tatematsu Y et al (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65(21):9628–9632

    Article  PubMed  CAS  Google Scholar 

  10. Shigoka M, Tsuchida A, Matsudo T et al (2010) Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Pathol Int 60(5):351–357

    Article  PubMed  CAS  Google Scholar 

  11. Chen ZL, Zhao XH, Wang JW et al (2011) MicroRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J Biol Chem 286(12):10725–10734

    Article  PubMed  CAS  Google Scholar 

  12. Wu CW, Ng SS, Dong YJ et al (2012) Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 61(5):739–745

    Article  PubMed  CAS  Google Scholar 

  13. Huang Z, Huang D, Ni S et al (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127(1):118–126

    Article  PubMed  CAS  Google Scholar 

  14. Tsuchida A, Ohno S, Wu W et al (2011) miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Sci 102(12):2264–2271

    Article  PubMed  CAS  Google Scholar 

  15. He L, Thomson JM, Hemann MT et al (2005) A microRNA polycistron as a potential human oncogene. Nature 435(7043):828–833

    Article  PubMed  CAS  Google Scholar 

  16. Voorhoeve PM, le Sage C, Schrier M et al (2006) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124(6):1169–1181

    Article  PubMed  CAS  Google Scholar 

  17. Johnson SM, Grosshans H, Shingara J et al (2005) RAS is regulated by the let-7 microRNA family. Cell 120(5):635–647

    Article  PubMed  CAS  Google Scholar 

  18. Mattie MD, Benz CC, Bowers J et al (2006) Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5:24

    Article  PubMed  Google Scholar 

  19. Yanaihara N, Caplen N, Bowman E et al (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9(3):189–198

    Article  PubMed  CAS  Google Scholar 

  20. Tanaka M, Oikawa K, Takanashi M et al (2009) Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS ONE 4(5):e5532

    Article  PubMed  Google Scholar 

  21. Diosdado B, van de Wiel MA, Terhaar Sive Droste JS et al (2009) MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 101(4):707–714

    Article  PubMed  CAS  Google Scholar 

  22. Connolly E, Melegari M, Landgraf P et al (2008) Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol 173(3):856–864

    Article  PubMed  CAS  Google Scholar 

  23. Ventura A, Young AG, Winslow MM et al (2008) Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132(5):875–886

    Article  PubMed  CAS  Google Scholar 

  24. Bonauer A, Carmona G, Iwasaki M et al (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324(5935):1710–1713

    Article  PubMed  CAS  Google Scholar 

  25. Manni I, Artuso S, Careccia S et al (2009) The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms. FASEB J 23(11):3957–3966

    Article  PubMed  CAS  Google Scholar 

  26. Ghosh AK, Shanafelt TD, Cimmino A et al (2009) Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. Blood 113(22):5568–5574

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by Scientific Research Program of Sichuan Provincial Health Department of China (110319).

Conflict of interest

The authors declare that no conflicts of interest exist.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guangjun Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhou, T., Zhang, G., Liu, Z. et al. Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. Int J Colorectal Dis 28, 19–24 (2013). https://doi.org/10.1007/s00384-012-1528-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-012-1528-1

Keywords

Navigation